Charles A. Nelson is professor of pediatrics and neuroscience at Harvard Medical School and director of research at Boston Children’s Hospital’s Developmental Medicine Center.

Charles A. Nelson
Research director
Boston Children's Hospital
From this contributor
How separating children from parents causes irreparable harm
Science teaches us that housing children in institution-like settings is likely to cause severe and permanent damage to their minds and bodies.

How separating children from parents causes irreparable harm
Romanian orphans reveal clues to origins of autism
Understanding autism features in children who were deprived of social contact as infants could offer clues to the condition.

Romanian orphans reveal clues to origins of autism
Explore more from The Transmitter
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.

Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.

Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.

Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.